Gang Chen - Shandong Pharmaceutical Executive Director
| 600529 Stock | 24.52 0.31 1.28% |
Director
Gang Chen is Executive Director of Shandong Pharmaceutical Glass
| Age | 47 |
| Address | Yaobo Road, Zibo, China, 256100 |
| Phone | 86 53 3325 9167 |
| Web | https://www.pharmglass.com |
Shandong Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0661 % which means that it generated a profit of $0.0661 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1163 %, meaning that it generated $0.1163 on every $100 dollars invested by stockholders. Shandong Pharmaceutical's management efficiency ratios could be used to measure how well Shandong Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Shandong Pharmaceutical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 266.3 M, whereas Other Current Assets are forecasted to decline to about 33.3 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Fuxiao Shen | PetroChina Co Ltd | 54 | |
| Ronghua Li | China Mobile Limited | 58 | |
| Ke Tang | China Telecom Corp | 50 | |
| Hui Liu | China Life Insurance | 54 | |
| Pizheng Li | China Mobile Limited | 58 | |
| Jun Li | China Telecom Corp | 48 | |
| Wensheng Huang | China Petroleum Chemical | 57 | |
| Fangfang Cai | Ping An Insurance | 50 | |
| Zhichun Zhang | Ping An Insurance | 48 | |
| Guiqing Liu | China Telecom Corp | 58 | |
| Wang Li | Kweichow Moutai Co | 51 | |
| Yonglin Li | China Petroleum Chemical | 57 | |
| Tao Wan | China Petroleum Chemical | 56 | |
| Hongbin Liu | China Petroleum Chemical | 61 | |
| Fangzheng Jiao | PetroChina Co Ltd | 61 | |
| Lixin Ren | PetroChina Co Ltd | 56 | |
| Yiqun Ling | China Petroleum Chemical | 61 | |
| Peng Zhao | China Life Insurance | 51 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0661 |
Shandong Pharmaceutical Leadership Team
Elected by the shareholders, the Shandong Pharmaceutical's board of directors comprises two types of representatives: Shandong Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Pharmaceutical's management team and ensure that shareholders' interests are well served. Shandong Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jun Zhang, GM Director | ||
| Yizhao Song, Chief Officer | ||
| Wansheng He, Deputy Manager | ||
| Bin Du, Deputy Manager | ||
| Xingjun Wang, Deputy Director | ||
| Gang Chen, Executive Director | ||
| Yucai Su, Deputy Manager |
Shandong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shandong Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0661 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 13.21 B | ||||
| Shares Outstanding | 663.61 M | ||||
| Shares Owned By Insiders | 20.63 % | ||||
| Shares Owned By Institutions | 23.40 % | ||||
| Price To Book | 2.06 X | ||||
| Price To Sales | 3.17 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Shandong Stock
Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.